Understanding the Shift from Relapsing-Remitting MS to Secondary-Progressive MS

Keep reading to learn what to expect if you were recently diagnosed with SPMS and how to navigate this new leg of your MS journey.
How SPMS Differs From RRMS
RRMS is characterized by relapses or flare-ups of symptoms that may linger for a few days or weeks and then ease up during a time of either full or partial remission.
There are two forms of SPMS:
- Active or relapsing SPMS, where you still have flare-ups and detectable MRI changes
- Inactive or nonrelapsing SPMS, when you no longer have flares and have no new or active MRI changes indicating inflammation
In both types of SPMS, symptoms tend to worsen slowly over time.
How Do You Know If RRMS Has Become SPMS?
The gradual progression from RRMS to SPMS can be hard to notice, and symptoms may worsen at individual rates. For some, it takes years, but in other cases, changes may occur more quickly.
Still, there are certain signs of the transition from RRMS to SPMS, such as:
- Balance or walking issues
- Bladder or bowel issues
- Cognitive changes, such as difficulty concentrating, processing information, or remembering
- Double vision
- Increased fatigue
- Muscle spasms or tightness
- Numbness in the arms or legs
While it can be difficult to nail down exactly when the transition happens, “Doctors look for slow worsening of neurologic function over a 6- to 12-month period in the absence of relapses,” says Kalina Sanders, MD, a board-certified neurologist and the director of the Baptist Comprehensive MS Clinic in Jacksonville, Florida.
In general, people have less inflammation with SPMS than they did with RRMS. But you can still experience relapses and MRI changes while the condition progresses to a phase of worsening nerve damage.
Be sure to tell your neurologist about any new or worsening symptoms you have and attend routine appointments, so the condition can be closely monitored.
What to Expect Once You’re Diagnosed With SPMS
Your treatment plan is likely to evolve after you’re diagnosed with SPMS.
Treatment may look a bit different if you have inactive or nonrelapsing SPMS, which has historically been harder to treat. “Until recently, no DMTs have provided significant delay in disability in those dealing with inactive SPMS,” says John R. Corboy, MD, a board-certified neurologist and professor of neurology at the University of Colorado School of Medicine in Aurora, Colorado.
“This is the first study to show significant slowing of progressive disability in inactive SPMS,” says Dr. Corboy. Dr. Sanders heralds the medication as “a shift in the treatment paradigm, from mainly symptomatic care to disease modification, [which finally] fills the longstanding treatment gap in nonactive SPMS.”
And more treatments like it for nonrelapsing SPMS may be coming down the pike.
Along with medication, your treatment plan for SPMS may include:
- Physical therapy to help improve your strength and balance
- Occupational therapy to learn efficient methods of doing daily tasks (e.g., cleaning, cooking, and laundry) and personal care (e.g., bathing and dressing)
- Mobility aids, such as a walker or wheelchair, to help you move about safely
- Support groups or talk therapy to help you work through the emotions of an SPMS diagnosis and connect with others who understand what you’re going through
As you navigate SPMS and its changing treatment landscape, be sure to advocate for your care. This may include bringing a list of questions or concerns to each checkup, taking notes at your appointments, or bringing a friend or family member along for support.
Questions to Ask Your Neurologist
- Have other causes of slowly worsening neurological function, separate from MS, been explored or ruled out?
- Is my SPMS active or inactive, and what does this mean for my treatment options?
- Am I a candidate for new therapies or a clinical trial?
- If a DMT is recommended, what are the potential risks and side effects?
- How can we measure whether the treatment plan is helping?
- Are there limitations in insurance coverage, especially if I change insurance or switch to Medicare?
- Are there adaptive strategies, medications, or mobility aids that could improve my daily function?
- What other lifestyle adjustments are important for me?
The Takeaway
- It’s common for relapsing-remitting multiple sclerosis to eventually progress to secondary progressive MS, but the process can take years and be difficult to track.
- Learning whether you have active (relapsing) or inactive (nonrelapsing) SPMS can help you and your care team tailor your treatment plan to your needs.
- Talk to your doctor about other ways to manage the condition and symptoms, including mental health support, mobility aids, occupational therapy, and physical therapy.
- Ziemssen T et al. Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies. Neurology, Neuroimmunology & Neuroinflammation. January 2023.
- Secondary Progressive Multiple Sclerosis (SPMS). National Multiple Sclerosis Society.
- Secondary Progressive Multiple Sclerosis (SPMS). Cleveland Clinic. July 30, 2025.
- Fox RJ et al. Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis. The New England Journal of Medicine. May 15/22, 2025.

Jason Paul Chua, MD, PhD
Medical Reviewer
Jason Chua, MD, PhD, is an assistant professor in the Department of Neurology and Division of Movement Disorders at Johns Hopkins School of Medicine. He received his training at the University of Michigan, where he obtained medical and graduate degrees, then completed a residency in neurology and a combined clinical/research fellowship in movement disorders and neurodegeneration.
Dr. Chua’s primary research interests are in neurodegenerative disease, with a special focus on the cellular housekeeping pathway of autophagy and its impact on disease development in diseases such as Parkinson disease. His work has been supported by multiple research training and career development grants from the National Institute of Neurological Disorders and Stroke and the American Academy of Neurology. He is the primary or coauthor of 14 peer-reviewed scientific publications and two peer-reviewed online learning modules from the American Academy of Neurology. He is also a contributing author to The Little Black Book of Neurology by Osama Zaldat, MD and Alan Lerner, MD, and has peer reviewed for the scientific journals Autophagy, eLife, and Neurobiology of Disease.

Jennifer Kelly Geddes
Author
Jennifer Kelly Geddes is a New York City-based freelance writer and editor, who covers health, wellness, pregnancy, and parenting. She has held positions at Food & Wine, Parenting, Seventeen, and Airbnb magazines and was a research editor at Parenting for more than a decade. Jennifer has also worked as a research editor for Kiwi, Scholastic Parent & Child, Dr. Oz: The Good Life, Modern Farmer, CR Fashion Book, V, VMan, Parents, and National Geographic Kids. She has created custom content for dozens of websites, including Care, SafeBee, Fisher-Price, Mastercard, the National Sleep Foundation, Realtor, Working Mother, Grandparents, Time Out New York KIDS, Good Housekeeping, and Chewy. She holds a BA from Mount Holyoke College and an MA from Columbia University. And she is the mom of two teen girls and a rescue pup named Django. An avid tennis player, cross-country skier, and yoga enthusiast, she divides her time between West Harlem in Manhattan and Ghent, New York.